Amgen vs. Novo Nordisk: Which Healthcare Giant's Stock Is a Better Buy in 2026?
· fool.com · popularity 19/100 · 0 similar stories today · Entrepreneurship & Startups (Business & Finance)
Read the original at fool.com →
Summary
Amgen's 9.9% revenue growth outpaces Novo Nordisk, but a 33.1% net margin and lower valuation multiples tell a different profitability story. The …
Found in: The Motley Fool. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 9.